Journal of the American Pharmacists Association
Fecha de publicación: 1 march 2017
DOI: https://doi.org/10.1016/j.japh.2017.01.004
Autores: Reina Haque, Jiaxiao Shi, Joanie Chung, Xiaoqing Xu, Chantal Avila, Christopher Campbell, Syed A. Ahmed, Lei Chen, Joanne E. Schottinger.
Background: Our objective was to examine the association between adherence to tyrosine kinase inhibitors (TKIs) and molecular monitoring and the risk of disease progression or mortality among patients with chronic phase chronic myeloid leukemia (CML).
Comentarios
Para dejar un comentario antes debes iniciar sesión:
¿No tienes una cuenta?
Regístrate a través de éste enlace.